![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[Article Abstract]](/e/graphics/abstractborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](tk6132contents.gif)
Acta Cryst. (2003). E59, o1367-o1369 [ doi:10.1107/S1600536803017744 ]
2-Methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine methanol solvate monohydrate
B. Capuano, I. T. Crosby, G. D. Fallon, E. J. Lloyd, E. Yuriev and S. J. Egan
Online 23 August 2003
Copyright © International Union of Crystallography
IUCr Webmaster